ClinConnect ClinConnect Logo
Search / Trial NCT00446706

Estimation of Intrinsic Positive End-Expiratory Pressure (PEEP) in Acute Respiratory Distress Syndrome (ARDS)

Launched by TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER, EL PASO · Mar 12, 2007

Trial Information

Current as of May 13, 2025

Completed

Keywords

Intrinsic Peep

ClinConnect Summary

Intrinsic PEEP (Positive-End Expiratory Pressure) was measured by end-expiratory occlusion method and estimated using formulas derived from measured expiratory flows and a postulated linear pressure-flow relationship during expiration in passive ARDS patients. Agreement between measured and estimated intrinsic PEEP was analyzed by Bland and Altman's method.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients 18 years of age or older with diagnosis of ARDS, as defined by the American- European Consensus Conference 4
  • Receiving mechanical ventilation.
  • Presence of autoPEEP by inspection of flow-time waveforms displayed by the mechanical ventilator.
  • Exclusion Criteria:
  • Known or suspected diagnosis of COPD or airflow limitation.
  • Next of kin not available to consent.
  • Contraindication to receive a muscle relaxant when measurements may be inaccurate without its administration.
  • Pregnancy

About Texas Tech University Health Sciences Center, El Paso

Texas Tech University Health Sciences Center, El Paso is a leading academic institution dedicated to advancing healthcare through innovative research, education, and clinical practice. As a prominent sponsor of clinical trials, the center focuses on improving patient outcomes by rigorously investigating new therapies and treatment protocols across various medical disciplines. With a commitment to excellence and ethical standards, Texas Tech El Paso fosters collaboration among researchers, healthcare professionals, and community partners to address pressing health challenges and enhance the quality of care in the region and beyond.

Locations

El Paso, Texas, United States

Patients applied

0 patients applied

Trial Officials

Juan Figueroa-Casas, MD

Principal Investigator

Texas Tech University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials